MedTrace Logo

Breakfast on Postprandial Hyperglycemia

NCT02411682 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2015-04-08

No results posted yet for this study

Summary

Reduction of postprandial hyperglycemia (PPHG) is a major target in the treatment of type 2 diabetes (T2D). Skipping breakfast has been consistently associated with higher HbA1c and overall PPHG in subjects with type 2 diabetes (T2D). Our aim was to explore the effect of skipping vs eating breakfast on PPHG after subsequent isocaloric (700kcal) lunch and dinner

Conditions

Interventions

OTHER

Breakfast eating (YesB)

On YesB day the patients will eat Breakfast at 8:00, Lunch at 13:30 and Dinner at 19:00

OTHER

Breakfast skipping (NoB)

On NoB day the patients will fast until lunch, then will eat Lunch at 13:30 and Dinner at 19:00

Sponsors & Collaborators

  • Tel Aviv University

    collaborator OTHER

  • Hospital de Clinicas Caracas

    lead OTHER

Principal Investigators

  • Daniela Jakubowicz, MD · Hospital de Clinicas Caracas

  • Daniela Jakubowicz, MD · E. Wolfson Medical Center. Israel

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-07-31
Completion
2015-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02411682 on ClinicalTrials.gov